0.000USD0.000盘前交易 08/03, 09:30 (美东)
关键数据
4.280今开
4.310最高
608.89K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.47%换手率
4.310昨收
4.135最低
1.68M成交额
亏损市盈率静
1.59市净率
0.00%股息率 TTM
-15.89%ROA
6.18052周最高
1.03量比
-6.02M净利润
128.55M总股本
-0.5786每股收益TTM
1.19Beta
-20.93%ROE
2.46052周最低
4.06%振幅
48.16%毛利率
544.98M总市值
-2.00回报/风险
3.36%风险率
操作建议
Cytek Biosciences Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名85/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.69。中期看,股价处于下降通道。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Cytek Biosciences Inc评分
压力支撑

由于公司未披露,未能获取相关数据
Cytek Biosciences Inc亮点
亮点风险
Cytek Biosciences Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Cytek Biosciences Inc
CTKB
4
Edwards Lifesciences Corp
EW
33
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Cytek Biosciences Inc简介
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
公司代码CTKB
公司Cytek Biosciences Inc
CEOJiang (Wenbin)
网址https://cytekbio.com
公司股东
常见问题
Cytek Biosciences Inc(CTKB)的当前股价是多少?
Cytek Biosciences Inc(CTKB)的当前股价是 4.22。
Cytek Biosciences Inc的股票代码是什么?
Cytek Biosciences Inc的股票代码是CTKB。
Cytek Biosciences Inc股票的52周最高点是多少?
Cytek Biosciences Inc股票的52周最高点是6.18。
Cytek Biosciences Inc股票的52周最低点是多少?
Cytek Biosciences Inc股票的52周最低点是2.46。
Cytek Biosciences Inc的市值是多少?
Cytek Biosciences Inc的市值是544.98M。
现在Cytek Biosciences Inc(CTKB)的股票是买入、持有还是卖出?
根据分析师评级,Cytek Biosciences Inc(CTKB)的总体评级为买入,目标价格为5.69。
Cytek Biosciences Inc(CTKB)股票的每股收益(EPS TTM)是多少
Cytek Biosciences Inc(CTKB)股票的每股收益(EPS TTM)是-0.52。